FIELD: pharmaceutical chemistry.
SUBSTANCE: invention relates to imidazo[1,2-b][1,2,4,5]tetrazine derivatives, specifically to 3-carboxymethyl-1-(imidazo[1,2-b][1,2,4,5]tetrazin-3-yl)-1H-benzo[d]imidazole-3-ium chloride, active against drug-sensitive and drug-resistant Neisseria gonorrhoeae and Mycobacterium tuberculosis.
EFFECT: obtaining 3-carboxymethyl-1-(imidazo[1,2-b][1,2,4,5]tetrazin-3-yl)-1H-benzo[d]imidazole-3-ium chloride, active against drug-sensitive and drug-resistant Neisseria gonorrhoeae and Mycobacterium tuberculosis.
1 cl, 2 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
4-ISOPROPYL-6-R-IMIDAZO[1,2-B][1,2,4,5]TETRAZIN-3(4H)- ES WITH ANTIBACTERIAL ACTIVITY AGAINST NEISSERIA GONORRHOEAE | 2020 |
|
RU2754554C1 |
ANTI-TUBERCULOSIS AGENTS BEING 3,7-DISUBSTITUTED [1,2,4]TRIAZOLO[1,5-b][1,2,4,5]TETRAZINES | 2022 |
|
RU2802300C1 |
3-ISOPROPOXY-6-R-IMIDAZO[1,2-B][1,2,4,5]TETRAZINES HAVING ANTIBACTERIAL ACTIVITY AGAINST NEISSERIA GONORRHOEAE | 2020 |
|
RU2767869C1 |
SELECTIVE ANTIBACTERIAL AGENTS, REPRESENTED BY 3-(AZOL-1-YL)-6-AMINO-SUBSTITUTED 1,2,4,5-TETRAZINES | 2017 |
|
RU2642882C1 |
ANTITUBERCULOUS THERAPEUTIC AGENT: COMPOSITION OF IMIDAZO[1,2-b]TETRAZINE AND PYRAZINAMIDE | 2013 |
|
RU2545458C2 |
3-GUANIDINO-6-R-TRIAZOLO[4,3-B][1,2,4,5]TETRAZINES WITH ANTIBACTERIAL ACTIVITY | 2018 |
|
RU2663890C1 |
SUBSTITUTED AZOLO[1,2,4,5]TETRAZINES - INHIBITORS OF ANTIBACTERIAL SERINE-THREONINE PROTEIN KINASES | 2011 |
|
RU2462466C1 |
QUATERNARY AMMONIUM DERIVATIVES OF 2-AMINOTHIOPHEN-3-CARBOXYLATES HAVING ANTI-TUBERCULOSIS ACTIVITY | 2016 |
|
RU2629369C1 |
5-METHYL-7-(3-NITRO-[1,2,4]TRIAZOL-1-YL)-[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE, HAVING ANTI-TUBERCULOSIS ACTIVITY AGAINST THE AGENT WITH MULTIPLE DRUG RESISTANCE, AND A METHOD FOR PRODUCTION THEREOF | 2018 |
|
RU2705591C1 |
COMPOUND OF 8-(4-METHYL-4H-1,2,4-TRIAZOL-3-YL)-6-(METHYLSULPHONYL)-2-(5-NITRO-2-FUROYL)-2,6-DIAZASPIRO[3.4]OCTANE, HAVING ANTI-TUBERCULOSIS ACTIVITY AGAINST MULTIDRUG-RESISTANT TUBERCULOSIS AGENT, AND METHOD FOR PRODUCTION THEREOF | 2023 |
|
RU2825646C1 |
Authors
Dates
2024-10-21—Published
2023-12-13—Filed